title: Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice.
authors.affiliation: Department of Neurology, Harvard Medical School and Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. lemere@cnd.bwh.harvard.edu
authors.forename: C A
authors.initials: CA
authors.lastname: Lemere
authors.forename: R
authors.initials: R
authors.lastname: Maron
authors.forename: E T
authors.initials: ET
authors.lastname: Spooner
authors.forename: T J
authors.initials: TJ
authors.lastname: Grenfell
authors.forename: C
authors.initials: C
authors.lastname: Mori
authors.forename: R
authors.initials: R
authors.lastname: Desai
authors.forename: W W
authors.initials: WW
authors.lastname: Hancock
authors.forename: H L
authors.initials: HL
authors.lastname: Weiner
authors.forename: D J
authors.initials: DJ
authors.lastname: Selkoe
mesh_terms: D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D000818:Animals; D000917:Antibody Formation; D001921:Brain / Q000473:pathology; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D058225:Plaque, Amyloid / Q000473:pathology
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor